Amit Ghate
Long/short equity, value

Inovio - Dilution And Catalysts Make It A Promising Short

In a previous article I suggested that investors shouldn't get too excited about individual snippets of news from Inovio (NYSEMKT:INO), as the company has a long history of similar news that ends up going nowhere. A few days later, respected analyst Adam Feuerstein made similar comments as well as giving a brief appraisal of the company's technological prospects.

At the time of my article, the stock was trading at a market cap of >$500M - though I opined that even $200M would have been a generous valuation. The stock subsequently fell nearly to my target, but now has bounced back to $460M. (Apparently Y Charts hasn't yet updated the number of shares outstanding.) The question then is: has...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details